RxDoctor Payments Data

Trilokesh Kidambi, MD

Gastroenterology · Duarte, CANPI 1679849574

Payments from drug & device makers

$1,174in general payments, 2019–2025

Across 21 payments — averaging $55.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Apollo Endosurgery US Inc$523
  • Olympus America Inc.$147
  • Deciphera Pharmaceuticals Inc.$146
  • Boston Scientific$96
  • Phathom Pharmaceuticals, Inc.$81
  • Braintree Laboratories, Inc.$67
  • plus $114 from 2 others

What the payments were for

  • Travel & lodging$37232%
  • Food & beverage$80268%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,174 in reported general payments places this provider in the 40th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California

Medicare billing

Part B allowed, 2024
$152,895
Medicare patients
651
Services billed
1,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase73$155,153
Humira(Cf) PenAdalimumab13$88,640
LinzessLinaclotide26$34,737
Mesalamine31$14,609
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates202$12,269
Sucralfate46$6,716
Colestipol Hcl45$3,970
Lansoprazole37$3,076
Omeprazole159$2,597
Dicyclomine Hcl71$2,303
Pantoprazole Sodium82$1,405
Famotidine75$1,115
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine13$451
Ondansetron Hcl167$383
Ondansetron OdtOndansetron14$337

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Duarte

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →